Surgical under-treatment of older adult patients with cancer: A systematic review and meta-analysis. Issue 4 (May 2022)

• Record Type: Journal Article
• Authors: Akinoso-Imran, Abdul Qadr; O'Rorke, Michael; Kee, Frank; Jordao, Haydee; Walls, Gerard; Bannon, Finian J.
• Is Part Of: Journal of geriatric oncology. Volume 13:Issue 4(2022)
• Page Start: 398
• Page End: 409
• Publication Date: 2022-05
• Subjects: under-treatment -- comorbidity -- stage -- performance status -- cancer -- survival; Geriatric oncology -- Periodicals; Neoplasms -- Periodicals; Aged -- Periodicals; Geriatric oncology; Electronic journals; Periodicals; 618.976994005
• DOI: 10.1016/j.jgo.2021.11.004
• Languages: English
• ISSNs: 1879-4068

Abstract

Abstract: Background : Older patients with cancer often have lower surgery rates and survival than younger patients, but this may reflect surgical contraindications of advanced disease, comorbidities, and frailty – and not necessarily under-treatment. Objectives : This review aims to describe variations in surgery rates and observed or net survival among younger (<75) and older (≥75) patients with breast, lung and colorectal cancer, while taking account of pre-existing health factors, in order to understand how under-treatment is defined and estimated in the literature. Method : MEDLINE, EMBASE, Web of Science and PubMed databases were searched for studies reporting surgery rates and observed or net survival among younger and older patients with breast, lung, and colorectal cancer. Study quality was assessed using the Newcastle Ottawa Scale, and random effects meta-analyses were used to combine study results. The I-squared statistic and subgroup analyses were used to assess heterogeneity. Results : Thirty relatively high-quality studies of patients with breast (230, 200; 71.9%), lung (77, 573; 24.2%), and colorectal (12, 407; 3.9%) cancers were identified. Compared to younger patients, older patients were less likely to receive surgical treatment for 1) breast cancer after adjusting for comorbidity, performance status (PS), functional status and patient choice, 2) lung cancer after accounting for stage, comorbidity, PS, and 3) colorectal cancer after adjusting for stage, comorbidity, and gender. The pooled unadjusted analyses showed lower surgery receipt in older patients with breast (odds ratio [OR] 0.31, 95% confidence interval [CI] 0.13—0.78), lung (OR 0.54, 95% CI 0.39—0.75), and colorectal (OR 0.59, 95% CI 0.51—0.68) cancer. In separate analyses, older patients with breast, lung and colorectal cancer had lower observed and net survival, compared to younger patients. Conclusions : Lower surgery rates in older patients may contribute to their poorer survival compared to younger patients. Future research quantifying under-treatment should include necessary clinical factors, patient choice, patient's quality of life and a statistically-robust approach, which will demonstrate how much of the survival deficit in older patients is due to their receiving lower surgery rates.